targiniq 10 mg/5 mg depottablett
mundipharma ab - naloxonhydrokloriddihydrat; oxikodonhydroklorid - depottablett - 10 mg/5 mg - stearylalkohol hjälpämne; oxikodonhydroklorid 10 mg aktiv substans; naloxonhydrokloriddihydrat 5,45 mg aktiv substans; laktosmonohydrat hjälpämne - kombinationer
targiniq 15 mg/7,5 mg depottablett
mundipharma ab - naloxonhydrokloriddihydrat; oxikodonhydroklorid - depottablett - 15 mg/7,5 mg - stearylalkohol hjälpämne; naloxonhydrokloriddihydrat 8,24 mg aktiv substans; oxikodonhydroklorid 15 mg aktiv substans; laktosmonohydrat hjälpämne - kombinationer
targiniq 2,5 mg/1,25 mg depottablett
mundipharma ab - naloxonhydrokloriddihydrat; oxikodonhydroklorid - depottablett - 2,5 mg/1,25 mg - stearylalkohol hjälpämne; naloxonhydrokloriddihydrat 1,37 mg aktiv substans; oxikodonhydroklorid 2,5 mg aktiv substans; laktosmonohydrat hjälpämne - kombinationer
targiniq 20 mg/10 mg depottablett
mundipharma ab - naloxonhydrokloriddihydrat; oxikodonhydroklorid - depottablett - 20 mg/10 mg - oxikodonhydroklorid 20 mg aktiv substans; naloxonhydrokloriddihydrat 10,9 mg aktiv substans; stearylalkohol hjälpämne; laktosmonohydrat hjälpämne - kombinationer
targiniq 30 mg/15 mg depottablett
mundipharma ab - naloxonhydrokloriddihydrat; oxikodonhydroklorid - depottablett - 30 mg/15 mg - oxikodonhydroklorid 30 mg aktiv substans; naloxonhydrokloriddihydrat 16,48 mg aktiv substans; stearylalkohol hjälpämne; laktosmonohydrat hjälpämne - kombinationer
targiniq 40 mg/20 mg depottablett
mundipharma ab - naloxonhydrokloriddihydrat; oxikodonhydroklorid - depottablett - 40 mg/20 mg - stearylalkohol hjälpämne; oxikodonhydroklorid 40 mg aktiv substans; naloxonhydrokloriddihydrat 21,8 mg aktiv substans; laktosmonohydrat hjälpämne - kombinationer
targiniq 5 mg/2,5 mg depottablett
mundipharma ab - naloxonhydrokloriddihydrat; oxikodonhydroklorid - depottablett - 5 mg/2,5 mg - stearylalkohol hjälpämne; laktosmonohydrat hjälpämne; naloxonhydrokloriddihydrat 2,73 mg aktiv substans; oxikodonhydroklorid 5 mg aktiv substans - kombinationer
targiniq 60 mg/30 mg depottablett
mundipharma ab - naloxonhydrokloriddihydrat; oxikodonhydroklorid - depottablett - 60 mg/30 mg - laktosmonohydrat hjälpämne; stearylalkohol hjälpämne; naloxonhydrokloriddihydrat 32,7 mg aktiv substans; oxikodonhydroklorid 60 mg aktiv substans
targiniq 80 mg/40 mg depottablett
mundipharma ab - naloxonhydrokloriddihydrat; oxikodonhydroklorid - depottablett - 80 mg/40 mg - laktosmonohydrat hjälpämne; stearylalkohol hjälpämne; oxikodonhydroklorid 80 mg aktiv substans; naloxonhydrokloriddihydrat 43,6 mg aktiv substans
brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastiska medel - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).